Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for an enhanced normalizing and healing profile of the skin.
Keywords: 2; and 3; biophotonic platform; chromophore; erythema; fluorescent light energy; inflammation; rosacea; subtype 1.